PlainRecalls
FDA Drug Moderate Class II Terminated

Procrit Epoetin Alfa 40,000 units/mL single use vial For Intravenouse or Subcutaneous Use Only, Rx only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320-1799, Manufactured for: Janssen Products, LP Horsham, PA 19044, NDC 59676-340-01

Reported: August 23, 2017 Initiated: August 4, 2017 #D-1086-2017

Product Description

Procrit Epoetin Alfa 40,000 units/mL single use vial For Intravenouse or Subcutaneous Use Only, Rx only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320-1799, Manufactured for: Janssen Products, LP Horsham, PA 19044, NDC 59676-340-01

Reason for Recall

Presence of particulate matter: Visible glass flakes identified as lamellae in some drug product vials.

Details

Recalling Firm
Amgen, Inc.
Units Affected
175,632 vials
Distribution
United States including Puerto Rico
Location
Thousand Oaks, CA

Frequently Asked Questions

What product was recalled?
Procrit Epoetin Alfa 40,000 units/mL single use vial For Intravenouse or Subcutaneous Use Only, Rx only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320-1799, Manufactured for: Janssen Products, LP Horsham, PA 19044, NDC 59676-340-01. Recalled by Amgen, Inc.. Units affected: 175,632 vials.
Why was this product recalled?
Presence of particulate matter: Visible glass flakes identified as lamellae in some drug product vials.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 23, 2017. Severity: Moderate. Recall number: D-1086-2017.